Alerts will be sent to your verified email
Verify Email
ZENITHHE
|
Zenith Health Care
|
Ishita Drugs & Inds.
|
Kabra Drugs
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
4.69 % | 8.34 % | 65.41 % |
|
5yr average Equity Multiplier
|
1.34 | 1.24 | -11.28 |
|
5yr Average Asset Turnover Ratio
|
1.59 | 1.36 | 0.0 |
|
5yr Avg Net Profit Margin
|
2.26 % | 5.01 % | 0.0 |
|
Price to Book
|
3.29 | 2.34 | 7.92 |
|
P/E
|
0.0 | 27.45 | 0.0 |
|
5yr Avg Cash Conversion Cycle
|
77.41 Days | 40.65 Days | 0.0 |
|
Inventory Days
|
70.5 Days | 24.87 Days | 0.0 |
|
Days Receivable
|
54.46 Days | 30.03 Days | 0.0 |
|
Days Payable
|
55.38 Days | 48.29 Days | 0.0 |
|
5yr Average Interest Coverage Ratio
|
47.8 | 25.37 | -836.53 |
|
5yr Avg ROCE
|
6.61 % | 11.35 % | 64.57 % |
|
5yr Avg Operating Profit Margin
|
2.14 % | 6.35 % | 0.0 |
|
5 yr average Debt to Equity
|
0.0 | 0.03 | -6.16 |
|
5yr CAGR Net Profit
|
-18.9 % | 6.4 % | 65.28 % |
|
5yr Average Return on Assets
|
3.55 % | 6.76 % | -21.32 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
28.74 % | 49.91 % | 0.0 |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
0.0 | 0.6 % | 0.0 |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
|
Zenith Health Care
|
Ishita Drugs & Inds.
|
Kabra Drugs
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|